Moreover, CKIP-1 can inhibit pathological cardiac hypertrophy by promoting dephosphorylation of histone deacetylase 4 (HDAC4) through recruiting serine/threonine protein phosphatase 2A (PP2A) [22]. Here, PTPA is linked to cardiac hypertrophy.